Research AppraisalSystematic Review

Reporting of Telehealth Implementation in Cystic Fibrosis: Scoping Review Using a Novel Theory-Based Evaluation Lens

Journal of medical Internet researchVagg, Tamara, Doherty, Robyn, Ranganathan, Sarath C et al.22 May 2026DOI

Clinical Snapshot

85CEBM
Evidence: ModerateSystematic Review

PICO Framework

P — PopulationCystic fibrosis patients receiving telehealth interventions
I — InterventionTelehealth interventions (primarily video calls with remote monitoring)
C — ComparatorNot applicable - scoping review evaluating reporting quality
O — OutcomesAdherence to standardized reporting frameworks (iCHECK-DH and TIDiER-telehealth scores)

Bottom Line

This scoping review of 98 studies reveals moderate adherence to standardized telehealth reporting frameworks in cystic fibrosis research, with significant gaps in implementation process documentation. While clinical outcomes and rationale are well-reported, critical details about feasibility, sustainability, safety protocols, and scalability remain underreported. For Australian CF clinicians, this highlights the need for more rigorous documentation when implementing telehealth services, particularly given the geographic challenges in CF care delivery. The findings suggest current evidence may be insufficient to guide robust telehealth implementation decisions, emphasizing the importance of comprehensive reporting standards. Clinicians should approach telehealth adoption cautiously, ensuring adequate documentation of implementation processes, patient safety measures, and equity considerations. The review provides a valuable framework for evaluating telehealth research quality and identifying evidence gaps that need addressing before widespread clinical adoption.

Evidence: Moderate

Key Findings

  • P Value: Not applicable for scoping review

  • Effect Size: iCHECK-DH median score 22/40 (55% adherent), TIDiER-telehealth median score 15/24 (62.5% adherent)

  • Primary Outcome: Moderate adherence to standardized telehealth reporting frameworks

  • Nnt Or Sensitivity: Range 11-29 for iCHECK, 6-23 for TIDiER across 98 studies

  • Confidence Interval: Not applicable for scoping review

Clinical Application

High feasibility for improving research reporting quality, moderate for clinical implementation guidance Highly relevant - Australia featured prominently in included studies, aligns with TGA digital health guidance and RACGP telehealth position CF care teams implementing or researching telehealth interventions

Abstract

BACKGROUND: Many inductive reviews exploring telehealth and its application in health care have identified missing or inconsistently reported implementation data, calling for a standardized approach to telehealth research. OBJECTIVE: Using cystic fibrosis (CF) as a case exemplar, this study evaluated the adherence of telehealth research to standardized reporting frameworks through a theory-based evaluation lens to assess implementation reporting quality and identify knowledge gaps and strengths across the literature. METHODS: We conducted an updated systematic review of the PubMed, Scopus, and Web of Science databases using a novel deductive approach to identify relevant scientific papers available in English and focusing on the delivery of telehealth interventions to CF populations as part of or alongside routine CF care. Two relevant reporting checklists were identified in the Equator Network database (Guidelines and Checklist for the Reporting on Digital Health Implementations [iCHECK-DH] and Template for Intervention Description and Replication for Telehealth [TIDiER-telehealth]) to extract data from the papers. Each checklist category was described as being "fully reported" (score=2), "partially reported" (score=1), and "did not report" (score=0) for each paper. An overall score was calculated for adherence to the checklists. RESULTS: In total, 98 studies published between 2006 and May 2025 were included in this review, with the majority appearing during the COVID-19 pandemic (2021-2022). Most studies were conducted in a single country, predominantly the United States, Australia, and the United Kingdom, and were published in medical journals. Telehealth was variably described, with video call-based models in combination with remote monitoring being most common. The median score was 22/40 (range 11-29, 55.0% adherent) for iCHECK and 15/24 (range 6-23, 62.5% adherent) for TIDiER, demonstrating moderate overall reporting quality. For iCHECK, ≥50% of studies fully reported 6/20 categories, partially reported 9/20 categories, and did not report 3/20 categories. For TIDiER, ≥50% of studies fully reported 4/12 categories, partially reported 6/12 categories, and did not report 1/12 categories, indicating persistent gaps in intervention description despite improved partial reporting. CONCLUSIONS: Key areas, such as justification for telehealth, target populations, and outcomes, are well documented, offering valuable insights into the rationale for and outcomes associated with telehealth. However, implementation processes remain underreported, partly due to the more recent adoption of frameworks like iCHECK and TIDiER. The clinical implications of the current evidence limit the implementation of telehealth in terms of the ability to assess feasibility and readiness for adoption; understand financial implications and plan sustainably; ensure patient safety, data protection, and equity; interpret outcome data in context; and share, replicate, or scale evidence-based models of care. Strengthening the commitment to standardized telehealth reporting will ultimately support clinical decision-making and improve the effective and equitable integration of telehealth into care.

References

  1. 1.Vagg, T., Doherty, R., Ranganathan, S. C., & Plant, B. J. (2026). Reporting of telehealth implementation in cystic fibrosis: Scoping review using a novel theory-based evaluation lens. Journal of Medical Internet Research, 28(5), e86194. https://doi.org/10.2196/86194
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service